Revenue

As Spearmint Energy rapidly expands its US battery storage portfolio, a new C-suite appointment signals the critical role of strategic communications.

A new industry survey reveals that AI workloads are causing observability costs to skyrocket, creating a crisis of trust and visibility for tech teams.

U.S. firms lose $1.9T annually not to the economy, but to a hidden 'Discretionary Effort Deficit.' A new playbook exposes the true cost of bad management.

Oracle is launching a massive ad campaign for its Project Jupiter data center, promising billions. But can it win over a divided community wary of its water use?

A new industry of expert guides is emerging to help patients navigate a broken healthcare system. Here’s how it works and why it’s growing so fast.

The acquisition of a profitable logistics specialist gives NANO Nuclear control over a critical bottleneck, accelerating its end-to-end clean energy strategy.

Vicor raises Q2 revenue forecast by 13% after securing a new OEM license, signaling its patented power technology is a critical asset in AI infrastructure.

The AI chip innovator's preliminary index inclusion boosts visibility, but can its powerful, efficient APU technology deliver on its market promise?

Amid a S$50B construction surge, one firm's logistics overhaul and green tech pivot reveal the strategy needed to power Singapore's ambitious future.

A new global repository by Zifo and the Pistoia Alliance aims to standardize biological data, promising to accelerate drug discovery and fix costly data silos.

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

From heirlooms to modern rifles, Americans are selling guns online like never before. But how does this new convenience balance with safety and the law?

A Healdsburg home is offered for $2M in Anthropic stock, a novel deal unlocking illiquid tech wealth for a rare, income-producing Wine Country asset.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

A breakthrough 'pap smear for the pancreas' that detects early cancer has secured major funding, offering new hope against one of the deadliest diseases.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

In an unprecedented move, top executives from competing Washington wineries are joining forces. Can their 'One Voice' rewrite the state's future on the national stage?

Struggling with losses, Nocera is betting its future on a $300M pivot into five of the world's most competitive tech sectors. Can it succeed?

A new report shows hospitals in a federal drug discount program provide less charity care than others, fueling calls for urgent federal reforms.

A new campaign asks global citizens to turn Mandela Day's 67 minutes into a year of sustained support for South Africa's most vulnerable children.